Addex Therapeutics (ADXN) Retained Earnings: 2022-2025
Historic Retained Earnings for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$430.8 million.
- Addex Therapeutics' Retained Earnings fell 11.12% to -$430.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$430.8 million, marking a year-over-year decrease of 11.12%. This contributed to the annual value of -$401.7 million for FY2024, which is 0.09% down from last year.
- As of Q2 2025, Addex Therapeutics' Retained Earnings stood at -$430.8 million, which was down 9.16% from -$394.7 million recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Retained Earnings ranged from a high of -$355.2 million in Q2 2022 and a low of -$430.8 million during Q2 2025.
- Its 3-year average for Retained Earnings is -$402.6 million, with a median of -$404.1 million in 2023.
- As far as peak fluctuations go, Addex Therapeutics' Retained Earnings dropped by 12.92% in 2023, and later grew by 5.23% in 2025.
- Addex Therapeutics' Retained Earnings (Quarterly) stood at -$363.2 million in 2022, then decreased by 11.88% to -$406.3 million in 2023, then climbed by 0.73% to -$403.4 million in 2024, then dropped by 11.12% to -$430.8 million in 2025.
- Its Retained Earnings was -$430.8 million in Q2 2025, compared to -$394.7 million in Q1 2025 and -$403.4 million in Q4 2024.